Caution urged with add-on DPP-4 inhibitors

Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
Source: MedWire News - Category: Consumer Health News Tags: Diabetes Source Type: news